A Comparison of Symptom Prevalence in Far Advanced Cancer, AIDS, Heart Disease, Chronic Obstructive Pulmonary Disease and Renal Disease

Solano, João Paulo Consentino; Gomes, Bárbara; Higginson, Irene J

doi:10.1016/j.jpainsymman.2005.06.007

Cited by 1,007 publications

(741 citation statements)

References 85 publications

Supporting

Mentioning

642

Contrasting

Unclassified

Order By: Relevance

“…There was no reported evidence with respect to age and sex (Solano et al. 2006; Clarke and Currie 2009). …”

Section: Resultsmentioning

confidence: 99%

“…of health anxiety in MS: 26.4% Pop‐based studies – anxiety prev: 21.9% (8.76–35.0%) Anxiety prev questionnaires vs admin data/medical records: 25.5% (16.7–34.3) vs. 15.4% (0–39.0) Chronic physical diseases Cardiovascular disease Janssen 2008 Search: 2007 # incl. studies 39 Meta‐analysis: no End‐of‐life CHF, COPD, CRF patients Mean age: 38–86 Sample size: not rep. Proxies and patients recruited, chart/medical record review CHF: 2–49% (anxiety prev) COPD: 32–57% CRF: 20–41% CRF terminal: 25% Solano 2006 Search: June 2004 # incl. studies 64 Meta‐analysis: no Adults with advanced cancer, AIDS, heart disease, COPD, renal disease Range: 19–10,379 Medical records, interviews with patients’ families, proxies used, prescriptions for psychotropic drugs Some studies conducted in clinical settings Prev of anxiety symptoms: Cancer: 13–79% AIDS: 8–34% Heart disease: 49% COPD: 51–75% Renal disease: 39–70% Tully 2013 Search: May 2011 # incl.…”

Section: Embasementioning

confidence: 99%

“…studies 12 Meta‐analysis: no Adults with (nonspecific) acute chest pain in acute care Range: 50–1300 Patients admitted to ED Clinical studies Symptom checklists 21–53.5% of NCCP patients had probable anxiety Women and younger patients – elevated anxiety Anxiety levels in NCCP similar to or higher than in CCP or healthy controls Campbell Burton 2013 Search: March 2011 # incl. studies 44 Meta‐analysis: yes Mean age: 66–71 years Range: 15–498 Population‐based (all stroke patients recruited from particular geographical area), hospital‐ and rehabilitation‐based (inpatients or those attending rehab facilities), community‐based (did not attempt to capture all stroke cases in geographic area) Clinical and community settings Anxiety symptom scales, clinical diagnoses, single question measure, researcher‐developed questions Prev of anxiety disorders: 18% (8–29) PD & GAD common Anxiety caseness (rating scales): 25% (21–28) 1/3 of patients with post‐stroke anxiety had pre‐stroke mood or anxiety High anxiety‐depression comorbidity Cancer Clarke 2009 – previously describedSolano 2006 – previously described Yang 2013 Search: Sep. 2012 # incl. studies 17 Meta‐analysis: yes Adults 18 + years from Mainland China Range: 380–2554 Unclear (assessed “patients”) Mainland China studies Clinical diagnosis, symptom checklists, self‐report questionnairesAnxiety prev: 49.7% (range: 20–89.1) in cancer, and 17.50% in the noncancer control groupVehling 2012 – previously described Lim 2011 Search: 2010 # incl.…”

Section: Embasementioning

confidence: 99%

“…studies 43 Meta‐analysis: yes Adult patients compared with spouses, IQR sample size: 145–270 Adult patients and healthy controls IQR:1328–25,245 Cases: outpatient clinic, database/cancer registry, hospitals, general population; recruitment: random sample (population‐based), patients treated in a certain time period; prescription for psychotropic drugs; Controls: comparator matching by sociodemographics, convenience sample, matched partner pair Clinical and community settings Symptom checklists, structured questionnaire for DSM, prescription of psychotropic drugs, clinical diagnosis Prev. long‐term cancer survivors vs. healthy controls: 17.9% (12.8–23.6), 13.9% (9.8–18.5); anxiety higher in cancer patients regardless of methodological factors Long‐term cancer survivors vs. spouses: 28% (22.3–33.9), 40.1% (25.4–55.9); age/sex effect not rep. Respiratory disease Janssen 2008 – previously describedSolano 2006 – previously described Davydow 2008 Search: April 2007 # incl. studies 10 Meta‐analysis: no Adult survivors in the United States and Germany 321 patients Sampling not mentioned – assessed patients following ICU discharge US and German studies Symptom checklists23–48% Diabetes Smith 2013 Search: July 2012 # incl.…”

Section: Embasementioning

confidence: 99%

“…studies 94 Meta‐analysis: yes 4007 adults age 18 + in palliative care; 10,071 adults 18 + in palliative care and oncological settings Patients from oncological, hematological, and palliative‐care settings Mostly Western studies Psychiatric interviews9.8% (6.8–13.2) in palliative‐care, and 10.3% (5.1–17.0) in oncological and hematological settingsJanssen 2008 – previously described Murtagh 2007 Search: April 2005 # incl. studies 60 Meta‐analysis: No Adult patients diagnosis of end‐stage renal disease Range: 19–5256 Clinical settingsStandardized psychiatric interview, survey, validated screening toolsAnxiety prev: 38% (12–52)Solano 2006 – previously described Trauma Mckechnie 2014 Search: June 2013 # incl. studies 13 Meta‐analysis: no Traumatic limb amputees, age 18 + Range: NR Military patients (including veterans from Vietnam, Iraq, Afghanistan) Mostly UK and US studies ICD or DSM diagnoses, symptom checklistsAnxiety ranged from 25.4–57% in this pop Chen 2010 Search: Dec. 2008 # incl.…”

Section: Embasementioning

confidence: 99%

See 4 more Smart Citations

A systematic review of reviews on the prevalence of anxiety disorders in adult populations

et al. 2016

View full text Add to dashboard Cite

BackgroundA fragmented research field exists on the prevalence of anxiety disorders. Here, we present the results of a systematic review of reviews on this topic. We included the highest quality studies to inform practice and policy on this issue.MethodUsing PRISMA methodology, extensive electronic and manual citation searches were performed to identify relevant reviews. Screening, data extraction, and quality assessment were undertaken by two reviewers. Inclusion criteria consisted of systematic reviews or meta‐analyses on the prevalence of anxiety disorders that fulfilled at least half of the AMSTAR quality criteria.ResultsWe identified a total of 48 reviews and described the prevalence of anxiety across population subgroups and settings, as reported by these studies. Despite the high heterogeneity of prevalence estimates across primary studies, there was emerging and compelling evidence of substantial prevalence of anxiety disorders generally (3.8–25%), and particularly in women (5.2–8.7%); young adults (2.5–9.1%); people with chronic diseases (1.4–70%); and individuals from Euro/Anglo cultures (3.8–10.4%) versus individuals from Indo/Asian (2.8%), African (4.4%), Central/Eastern European (3.2%), North African/Middle Eastern (4.9%), and Ibero/Latin cultures (6.2%).ConclusionsThe prevalence of anxiety disorders is high in population subgroups across the globe. Recent research has expanded its focus to Asian countries, an increasingly greater number of physical and psychiatric conditions, and traumatic events associated with anxiety. Further research on illness trajectories and anxiety levels pre‐ and post‐treatment is needed. Few studies have been conducted in developing and under‐developed parts of the world and have little representation in the global literature.

show abstract

“…There was no reported evidence with respect to age and sex (Solano et al. 2006; Clarke and Currie 2009). …”

Section: Resultsmentioning

confidence: 99%

Section: Embasementioning

confidence: 99%

Section: Embasementioning

confidence: 99%

Section: Embasementioning

confidence: 99%

Section: Embasementioning

confidence: 99%

See 3 more Smart Citations

A systematic review of reviews on the prevalence of anxiety disorders in adult populations

et al. 2016

View full text Add to dashboard Cite

show abstract

Caring for the Older Person With Chronic Obstructive Pulmonary Disease

Fried¹,

Fragoso²,

Rabow³

2012

JAMA

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease (COPD) is a common disease in elderly patients. It is characterized by high symptom burden, healthcare utilization, mortality, and unmet needs of both patients and their caregivers. The treatment of the older patient with COPD is highly challenging. Although COPD is a major cause of respiratory failure and dyspnea in the elderly, multiple other disease entities, including heart failure, pulmonary embolism, and anxiety; medication effects; and other conditions, including deconditioning and malnutrition; may exacerbate COPD symptoms. Randomized controlled trials, which provide the strongest evidence for guideline recommendations, may underestimate the risk of adverse effects of interventions for older patients with COPD. The focus of guidelines on disease-modifying therapies may not address the full spectrum of both patient and caregiver needs engendered by the increasing burdens of advanced disease, particularly the high rates of bothersome symptoms, risk of functional and cognitive decline, and need for end-of-life care planning. Older patients tend to have a substantial disease burden coupled with functional and cognitive decline complicating the successful implementation of COPD treatments. Meeting the many needs of older COPD patients and their families requires that clinicians supplement guideline-recommended care with treatment decision making that takes into account older persons’ comorbid conditions, recognizes the trade-offs engendered by the increased risk of adverse events, focuses on symptom relief and function, and prepares patients and their loved ones for further declines in the patient’s health and their end-of-life care. A case of COPD in an 81 year old man hospitalized with severe dyspnea and respiratory failure is presented. This case highlights both the challenges in managing COPD in the elderly and the limitations in applying guidelines to geriatric patients.

show abstract

A Comparison of Hospitalized Patients With Heart Failure and Cancer Referred to Palliative Care

et al. 2020

View full text Add to dashboard Cite

IMPORTANCE Growing evidence shows that palliative care (PC) improves treatment outcomes in patients with heart failure (HF), but few large-scale studies have prospectively evaluated the processes and outcomes associated with PC consultation for such patients in the real world.OBJECTIVE To characterize processes and outcomes of PC consultations for hospitalized patients with HF compared with patients with cancer.

show abstract

A Comparison of Symptom Prevalence in Far Advanced Cancer, AIDS, Heart Disease, Chronic Obstructive Pulmonary Disease and Renal Disease

Cited by 1,007 publications

References 85 publications

A systematic review of reviews on the prevalence of anxiety disorders in adult populations

A systematic review of reviews on the prevalence of anxiety disorders in adult populations

Caring for the Older Person With Chronic Obstructive Pulmonary Disease

A Comparison of Hospitalized Patients With Heart Failure and Cancer Referred to Palliative Care

Contact Info

Product

Resources

About